Molecular Classification Substitutes for the Prognostic Variables Stage, Age, and MYCN Status in Neuroblastoma Risk Assessment

Molecular Classification Substitutes for the Prognostic Variables Stage, Age, and MYCN Status in Neuroblastoma Risk Assessment

BACKGROUND: Current risk stratification systems for neuroblastoma patients consider clinical, histopathological, and genetic variables, and additional prognostic markers have been proposed in recent years. We here sought to select highly informative covariates in a multistep strategy based on consec...

Full description

Bibliographic Details
Main Authors: Carolina Rosswog, Rene Schmidt, André Oberthuer, Dilafruz Juraeva, Benedikt Brors, Anne Engesser, Yvonne Kahlert, Ruth Volland, Christoph Bartenhagen, Thorsten Simon, Frank Berthold, Barbara Hero, Andreas Faldum, Matthias Fischer
Format: Article
Language:English
Published: Elsevier 2017-12-01
Series:Neoplasia: An International Journal for Oncology Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558617302695

Internet

http://www.sciencedirect.com/science/article/pii/S1476558617302695

Similar Items